Your browser doesn't support javascript.
loading
Multiple nonmelanoma skin cancers in a patient with epidermolytic hyperkeratosis on long-standing retinoid therapy.
Sarnoff, Deborah S; Saini, Ritu.
Afiliación
  • Sarnoff DS; Cosmetique Dermatology, Laser, and Plastic Surgery LLP, New York, NY, USA.
J Drugs Dermatol ; 7(5): 475-8, 2008 May.
Article en En | MEDLINE | ID: mdl-18505142
ABSTRACT
Epidermolytic hyperkeratosis is a rare genetic disorder of keratinization. In childhood, patients are erythrodermic and have a compromised stratum corneum, replaced with generalized hyperkeratosis as the patients age. Treatment consists of topical emollients as well as, topical and oral retinoids. Ultraviolet (UV) light, often in combination with psoralen ultraviolet A (PUVA) is widely used as a therapeutic modality for a multitude of hyperproliferative disorders. Although not strictly indicated for epidermolytic hyperkeratosis, it has been utilized as experimental treatment, particularly in the days prior to retinoids. Psoralen ultraviolet A has also been implicated in the development of nonmelanoma skin cancers, especially, squamous cell carcinoma (SCC). Retinoids are well-known to protect against nonmelanoma skin. A patient with epidermolytic hyperkeratosis with multiple nonmelanoma skin cancers, previously treated with PUVA and long-standing oral retinoids is reported.
Asunto(s)
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Terapia PUVA / Retinoides / Neoplasias Cutáneas / Hiperqueratosis Epidermolítica Tipo de estudio: Etiology_studies Idioma: En Revista: J Drugs Dermatol Año: 2008 Tipo del documento: Article País de afiliación: Estados Unidos
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Terapia PUVA / Retinoides / Neoplasias Cutáneas / Hiperqueratosis Epidermolítica Tipo de estudio: Etiology_studies Idioma: En Revista: J Drugs Dermatol Año: 2008 Tipo del documento: Article País de afiliación: Estados Unidos